Literature DB >> 28976867

Clonal Hematopoiesis and Atherosclerosis.

Siddhartha Jaiswal1, Pradeep Natarajan2, Benjamin L Ebert1,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28976867     DOI： 10.1056/NEJMc1710381

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.

Authors:  José J Fuster; Kenneth Walsh
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

Review 2.  Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.

Authors:  Sumeet A Khetarpal; Arman Qamar; Alexander G Bick; José J Fuster; Sekar Kathiresan; Siddhartha Jaiswal; Pradeep Natarajan
Journal:  J Am Coll Cardiol       Date:  2019-07-30       Impact factor: 24.094

Review 3.  Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond.

Authors:  Keith A Sikora; Kristina V Wells; Ertugrul Cagri Bolek; Adrianna I Jones; Peter C Grayson
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

4.  TET family dioxygenases and the TET activator vitamin C in immune responses and cancer.

Authors:  Xiaojing Yue; Anjana Rao
Journal:  Blood       Date:  2020-09-17       Impact factor: 22.113

Review 5.  Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia.

Authors:  Robert P Hasserjian; David P Steensma; Timothy A Graubert; Benjamin L Ebert
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

6.  Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.

Authors:  Katharina C Kiefer; Sebastian Cremer; Evangelia Pardali; Birgit Assmus; Khalil Abou-El-Ardat; Klara Kirschbaum; Lena Dorsheimer; Tina Rasper; Alexander Berkowitsch; Hubert Serve; Stefanie Dimmeler; Andreas M Zeiher; Michael A Rieger
Journal:  ESC Heart Fail       Date:  2021-03-28

7.  Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021.

Authors:  Tariq I Mughal; Bethan Psaila; Daniel J DeAngelo; Giuseppe Saglio; Richard A Van Etten; Jerald P Radich
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

Review 8.  Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.

Authors:  Elizabeth A Comen; Robert L Bowman; Maria Kleppe
Journal:  Front Cell Dev Biol       Date:  2018-06-12

9.  The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages.

Authors:  David M Calcagno; Richard P Ng; Avinash Toomu; Claire Zhang; Kenneth Huang; Aaron D Aguirre; Ralph Weissleder; Lori B Daniels; Zhenxing Fu; Kevin R King
Journal:  Sci Immunol       Date:  2020-09-25

Review 10.  Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.

Authors:  Anna S Nam; Ronan Chaligne; Dan A Landau
Journal:  Nat Rev Genet       Date:  2020-08-17       Impact factor: 53.242
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.